![]() |
|
|
1 Clinical Pharmacology and Toxicology Center, Department of Pharmacology, University of Kansas Medical Center, Kansas City, Kansas
Within 4 hours after i.v. administration (5 or 50 mg/kg) of 14C-ethacrynic acid (EA), 60 to 70% was excreted into the bile of rats. Less than 25% was EA and the remainder was biotransformation products. The two major metabolites in bile were identified; one was the glutathione adduct of EA (EA-GSH) and the other was EA-mercapturate. Approximately 40% of either dose was excreted as EA-GSH. EA-mercapturate accounted for 18% of the low dose and 30% of the high dose excreted into bile. Dogs excreted 57% of a 5 mg/kg dose (i.v.) into bile within 4 hours. Less EA was metabolized by the dog than the rat; 38% of the radioactivity excreted into dog bile was in the form of the parent drug. In addition to the two metabolites of EA found in rat bile, the dog formed a cysteine adduct of EA (EA-cysteine). The dog excreted 25, 11 and 9% of the dose of EA as EA-mercapturate, EA-cysteine and EA-GSH, respectively. Seventeen percent of the 14C excreted into the bile remained unidentified.
Submitted on May 6, 1974
This article has been cited by other articles:
![]() |
R. G. Tirona and K. S. Pang Bimolecular Glutathione Conjugation Kinetics of Ethacrynic Acid in Rat Liver: In Vitro and Perfusion Studies J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1230 - 1241. [Abstract] [Full Text] |
||||